Company Overview of The Jackson Laboratory
The Jackson Laboratory conducts mammalian genetics research in the United States. It offers scientific services and genetic resources to laboratories internationally, and educates students of various ages through courses, internships, and programs. The company also provides scientific resources, techniques, software, and data to scientists internationally. It offers high school internships, pre and post-doctoral opportunities, and collaborative education programs. The company discovers genetic basis for preventing, treating, and curing human diseases in the areas of cancers, computational biology and bioinformatics, developmental and reproductive biology, immunology, metabolic diseases, and ...
600 Main Street
Bar Harbor, ME 04609
Founded in 1929
Key Executives for The Jackson Laboratory
Chief Executive Officer and President
Chief Operating Officer and Executive Vice President
Director of Genetic Resource Science
Chair of Research and Trustee
Compensation as of Fiscal Year 2017.
The Jackson Laboratory Key Developments
The Jackson Laboratory and Seven Bridges Collaborate to Build Centralized Data Platform to Advance Cancer Research
Oct 17 17
The Jackson Laboratory and Seven Bridges announced a new collaboration to build an NCI-funded data platform to accelerate translational research using patient-derived tumor xenograft (PDX) datasets. This joint initiative will establish a PDX Data Commons and Coordinating Center to support PDXNet, a collaborative network that coordinates large-scale testing for preclinical therapeutic cancer drugs in PDX trials. In PDX trials, tumor models are created using fragments of a patient's tumor that can be propagated in mice to supply test tissue that can be used for research. Researchers can use the models to test multiple drugs, alone and/or in various combinations, and glean insight into drug responses, providing a clinical trial roadmap for piloting treatments for patients with tumors of similar molecular profiles. The PDX approach has gained significant traction in the cancer research community due to its increased precision in measuring drug-response. In 2016, the NCI decided to refocus its repository of cancer models, which has long been dominated by the NCI60 panel of human cancer cell lines, to include PDX models for cancer drug screening.
The Jackson Laboratory Presents at American Society of Human Genetics Annual Meeting, Oct-17-2017 through Oct-21-2017
Oct 15 17
The Jackson Laboratory Presents at American Society of Human Genetics Annual Meeting, Oct-17-2017 through Oct-21-2017. Venue: Orlando, Florida, United States. Presentation Date & Speakers: Oct-19-2017, Ryan Tewhey. Oct-20-2017, L. Kaye.
The Jackson Laboratory Presents at Global Precision Medicine & Biomarkers Leaders Summit, Sep-21-2017 11:45 AM
Sep 19 17
The Jackson Laboratory Presents at Global Precision Medicine & Biomarkers Leaders Summit, Sep-21-2017 11:45 AM. Venue: Holiday Inn, Munich City Centre, Hochstrasse 3, Munich, Germany. Speakers: Honey Reddi, Clinical Laboratory Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|